Corporate Banner
Satellite Banner
Next Gen Sequencing
Scientific Community
Become a Member | Sign in
Home>News>This Article

BioDatomics Receives New Investment

Published: Friday, April 25, 2014
Last Updated: Friday, April 25, 2014
Bookmark and Share
Grant will be used to drive growth of NGS data analysis platform for greater genomic research productivity.

BioDatomics™ has received a grant from the National Institutes of Health (NIH) and a capital investment from the Maryland Department of Business and Economic Development’s (MDBED) Maryland Venture Fund (MVF). These strategic investments will allow the company to further expand the capabilities of their next generation sequencing (NGS) data analysis platform, BioDT™.

The NIH continues to support NGS projects that focus on solving Big Data challenges associated with genomic research, and on democratizing access to advanced analysis platforms. With this NIH grant, “Building an open-source cloud-based computational platform to improve data access,” BioDatomics will further expand its open –source toolset, bringing these added capabilities to researchers and bioinformaticians alike.

“BioDatomics and the NIH share a mutual goal of accelerating genomic-based discoveries,” said Alan Taffel, President of BioDatomics. “While NGS funding has traditionally focused on generating new data, there is now an obvious need for NGS users to be able to glean insights from that data more quickly and intuitively.” 

In addition to the NIH grant, BioDatomics also received an investment from the MVF, which provides capital to innovative Maryland-based technology companies. Recognizing the avalanche of NGS data being generated by academic and commercial research organizations, and the need to analyze that data more efficiently, MVF took the opportunity to invest in a platform created specifically for that purpose.

“BioDatomics operates at the intersection of two of Maryland’s fastest-growing sectors — biotechnology and big data. We are proud to make this investment in BioDatomics and look forward to their growth and success in Maryland,” DBED Secretary Dominick Murray said. “Supporting entrepreneurs and small businesses in high-tech, high-growth fields is critical to the success of our economy and State. Companies like BioDatomics are facilitating the development of cutting-edge medicines, vaccines and technologies that keep us safer, healthier and better-connected than ever before.”

 “The investment from the Maryland Venture Fund serves as a validation of our approach and provides significant strategic value well beyond a financial commitment,” Taffel said.

Although several companies have recently entered the NGS data analysis market, BioDatomics is the only one to have developed an open-source solution built on the popular and powerful Hadoop® Big Data analysis engine, which allows pipelines to execute up to 100 times faster than traditional platforms. BioDT also enhances productivity by integrating many popular genomic analysis tools into a single platform that provides drag-and-drop editing, real-time collaboration, visualized results, and intuitive table manipulation. The platform is available as a software license and will shortly be released as a cloud-based service as well.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Research at St Thomas’s Hospital Exploring Causative Factors of Atopic Eczema and Food Allergy in Infants
Carsten Flohr and his research group at St Thomas’s hospital, London are currently investigating the interaction between skin and gut microbiota in relation to the associated risk of atopic eczema (AE) and food allergy in infants.
Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
Manipulating microbes maximizes tumor immunity in mice.
Proteins Crucial to Loss of Hearing Identified
Proteins play key role in genes that help auditory hair cells grow.
New Virus Identified In Blood Supply
Scientists have discovered a new virus that can be transmitted through the blood supply.
Far-reaching Genetic Study of 1,000 UK People
300,000 gene variants from 1,000 people made publically available via F1000Research.
DNA Alterations as Among Earliest to Occur in Lung Cancer Development
Genetic footprints of precancer detectable in some blood samples.
Targeting DNA
Protein-based sensor could detect viral infection or kill cancer cells.
Genetic Sleuthing
Sabeti team applies Ebola methods to shed light on spread of Lassa fever.
Seeking “Gold Standard” Wastewater Treatments
Metagenomic analyses lend insights into how microbes break down wastewater contaminants.
Using Genetic Sequencing to Manage Cancer in Children
A team of scientists have investigated the feasibility of incorporating clinical sequencing information into the care of young cancer patients.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos